Anymentionof Mino-WrapMino-Lokis our leadassetOnly biotechwith 2 Myron'son theleadershipteamI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.An actualiMSCupdateI/ONTAKis our leadassetWe willhaveexclusivityWe had aphase 2btrial with100%efficacyI'm ashareholdermyselfInsidersinvested$26.5mMyron Holubiakand I founded aprivatecompany in2013Our Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022Hemorrhoidsis a $2BmarketWe will openupinternationalsites forMino-Lok trialWe expect tofinish theMino-Loktrial this yearI/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BI won't diluteshareholdersWe haveenough cashto go wellinto 2023Not manycompaniesthis size with2 late stageassetsThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoidsAnymentionof Mino-WrapMino-Lokis our leadassetOnly biotechwith 2 Myron'son theleadershipteamI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.An actualiMSCupdateI/ONTAKis our leadassetWe willhaveexclusivityWe had aphase 2btrial with100%efficacyI'm ashareholdermyselfInsidersinvested$26.5mMyron Holubiakand I founded aprivatecompany in2013Our Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022Hemorrhoidsis a $2BmarketWe will openupinternationalsites forMino-Lok trialWe expect tofinish theMino-Loktrial this yearI/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BI won't diluteshareholdersWe haveenough cashto go wellinto 2023Not manycompaniesthis size with2 late stageassetsThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"There are noFDAapproveddrugs to treathemorrhoids

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Any mention of Mino-Wrap
  2. Mino-Lok is our lead asset
  3. Only biotech with 2 Myron's on the leadership team
  4. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  5. An actual iMSC update
  6. I/ONTAK is our lead asset
  7. We will have exclusivity
  8. We had a phase 2b trial with 100% efficacy
  9. I'm a shareholder myself
  10. Insiders invested $26.5m
  11. Myron Holubiak and I founded a private company in 2013
  12. Our Halo-Lido trial will have final patient by end of 2022
  13. We intend to submit a BLA in 2H 2022
  14. Hemorrhoids is a $2B market
  15. We will open up international sites for Mino-Lok trial
  16. We expect to finish the Mino-Lok trial this year
  17. I/ONTAK was the best deal I ever made
  18. I/ONTAK's potential market is >$300m
  19. Mino-Lok potential market >$1B
  20. I won't dilute shareholders
  21. We have enough cash to go well into 2023
  22. Not many companies this size with 2 late stage assets
  23. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  24. There are no FDA approved drugs to treat hemorrhoids